Price
Target price
€39.34
€39.34
-0.590%
-0.23
-0.590%
€41.15
27.09.24 / Tradegate
WKN: 529882 / Symbol: CORT / Name: Corcept / Stock / Pharmaceuticals / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Corcept Therapeutics Inc. Stock
The price for the Corcept Therapeutics Inc. stock decreased slightly today. Compared to yesterday there is a change of -€0.230 (-0.590%).
With 18 Buy predictions and not the single Sell prediction the community is currently very high on Corcept Therapeutics Inc..
With a target price of 41 € there is a slightly positive potential of 4.22% for Corcept Therapeutics Inc. compared to the current price of 39.34 €.
Pros and Cons of Corcept Therapeutics Inc. in the next few years
Pros
?
S********** s********
?
M***** P*******
?
C******** o* t** e**********
Cons
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Corcept Therapeutics Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Corcept Therapeutics Inc. | -0.590% | 3.882% | 26.903% | 32.013% | 31.133% | 122.260% | 198.800% |
| Rockwell Medical Inc. | -3.920% | -18.871% | 16.764% | 86.332% | 83.968% | -45.744% | -89.352% |
| Gritstone Oncology Inc | 1.380% | -2.785% | 23.799% | -52.627% | -70.883% | -94.499% | -93.238% |
| Pacira Pharmaceuticals | 3.200% | -1.527% | 0.781% | -58.387% | -56.711% | -73.992% | -64.340% |
Comments
Corcept Therapeutics Incorporated (NASDAQ: CORT) had its price target raised by analysts at Piper Sandler from $38.00 to $67.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for CORT provided by MarketBeat
Corcept Therapeutics Incorporated (NASDAQ: CORT) had its price target raised by analysts at Piper Sandler from $35.00 to $38.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for CORT provided by MarketBeat
Corcept Therapeutics Incorporated (NASDAQ: CORT) had its price target raised by analysts at HC Wainwright from $40.00 to $45.00. They now have a "buy" rating on the stock.
Show more
Ratings data for CORT provided by MarketBeat
